Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-24-108293
Filing Date
2024-10-15
Accepted
2024-10-15 06:55:19
Documents
1
Group Members
DEVESH GANDHI

Document Format Files

Seq Description Document Type Size
1 SC 13G/A tm2426101d2_sc13ga.htm SC 13G/A 71205
  Complete submission text file 0001104659-24-108293.txt   72888
Mailing Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139 617-498-0020
Mersana Therapeutics, Inc. (Subject) CIK: 0001442836 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-90033 | Film No.: 241369209
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 20 PARK PLAZA 4TH FLOOR BOSTON MA 02116
Business Address 20 PARK PLAZA 4TH FLOOR BOSTON MA 02116 617.284.6952
SILVERARC CAPITAL MANAGEMENT, LLC (Filed by) CIK: 0001816307 (see all company filings)

EIN.: 834542901 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A